BIOMARIN PHARMACEUTICAL INC.
BMRN · NASDAQ
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
Market Data
Price
$53.91
-0.30 (-0.55%)
Market Cap$10.37B
P/E Ratio29.72
EPS$—
52W High$66.28
52W Low$50.76
Beta0.24
Data from Finnhub · Updated May 1, 2026